Profile data is unavailable for this security.
About the company
Bioton SA is a Poland-based company active in the pharmaceutical sector. The Company is engaged in research, development and wholesale trade of pharmaceutical and biotechnological products. The Company's portfolio consists of oral hypoglycemic drugs (metformin and glimepride) as well as recombinant human insulin in pharmaceutical substance form and for injections. Additionally, the Company provides advertising services. As of December 31, 2011, the Company formed a capital group and operated through its subsidiaries, including BIOTON TRADE Sp. z o.o., Mindar Holdings Ltd, Germonta Holdings Ltd, Tricel SA, SciGen Ltd and BioPartners Holdings AG, among others. On June 12, 2014, it sold a 50% stake in Copernicus Sp. z o.o.
- Revenue in PLN (TTM)295.81m
- Net income in PLN-2.82m
- Incorporated2004
- Employees363.00
- LocationBioton SAul. Staroscinska 5WARSZAWA 02-516PolandPOL
- Phone+48 227214000
- Fax+48 227211333
- Websitehttps://bioton.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genomtec SA | 15.00k | -11.01m | 77.28m | -- | -- | 7.47 | -- | 5,152.11 | -0.7485 | -0.7485 | 0.001 | 0.6869 | 0.0009 | -- | 0.0143 | -- | -65.47 | -89.96 | -82.11 | -113.38 | -54,120.00 | -4,379.72 | -73,393.34 | -17,225.07 | 2.82 | -39.82 | 0.1409 | -- | 0.00 | -63.42 | -24.35 | -- | -34.54 | -- |
| Hyenergy SA | 3.29m | 169.85k | 77.91m | 27.00 | -- | 3.95 | 318.90 | 23.69 | -0.0936 | -0.0936 | 0.1654 | 0.5878 | 0.1821 | 0.1259 | 0.7741 | -- | 0.9403 | 2.39 | 1.28 | 3.35 | 99.70 | 77.46 | 5.16 | 3.11 | 1.30 | 1.17 | 0.00 | -- | 192.83 | 19.47 | 100.30 | -- | -45.79 | -- |
| Urteste SA | 0.00 | -5.47m | 78.75m | 34.00 | -- | 3.36 | -- | -- | -3.88 | -3.88 | 0.00 | 15.35 | 0.00 | -- | -- | -- | -15.56 | -29.65 | -18.99 | -31.35 | -- | -45,933.33 | -- | -623,333.30 | -- | -- | 0.0128 | -- | -- | -- | 35.00 | -- | 197.79 | -- |
| Nanogroup SA | -6.90k | -6.93m | 85.19m | -- | -- | 7.30 | -- | -- | -0.1844 | -0.1844 | -0.0002 | 0.3553 | -0.0003 | 2.64 | -- | -- | -30.59 | -29.50 | -51.55 | -33.80 | -- | 66.72 | -- | -2,258.26 | 0.9785 | -464.18 | 0.00 | -- | 3.96 | -64.09 | 34.50 | -- | 3.07 | -- |
| Poltreg SA | 0.00 | -24.56m | 128.24m | 33.00 | -- | 2.59 | -- | -- | -5.27 | -5.27 | 0.00 | 10.61 | 0.00 | 16.45 | -- | 0.00 | -25.87 | -9.02 | -29.62 | -10.18 | -- | -659.36 | -- | -854.23 | 2.65 | -- | 0.1365 | -- | -74.98 | -6.89 | -38.06 | -- | 83.47 | -- |
| Mabion SA | 14.81m | -59.30m | 133.02m | 204.00 | -- | 1.90 | -- | 8.98 | -3.67 | -3.67 | 0.9164 | 4.33 | 0.0988 | 8.10 | 27.25 | 72,602.94 | -39.56 | 0.5366 | -54.81 | 1.06 | -178.55 | 58.34 | -400.37 | 0.9643 | 0.2276 | -- | 0.04 | -- | -54.50 | -- | -115.35 | -- | 6.00 | -- |
| Molecure SA | 5.11m | -24.42m | 152.46m | 71.00 | -- | 1.70 | -- | 29.82 | -1.20 | -1.20 | 0.2493 | 4.34 | 0.0553 | -- | 7.01 | 50,119.41 | -26.42 | -3.15 | -27.53 | -3.30 | 51.48 | 93.34 | -477.67 | -15.45 | -- | -- | 0.0588 | -- | -40.47 | 278.20 | -10.27 | -- | 12.49 | -- |
| BIOTON SA | 295.81m | -2.82m | 346.89m | 363.00 | -- | 0.5859 | 9.81 | 1.17 | -0.0329 | -0.0329 | 3.45 | 6.90 | 0.3814 | 2.02 | 8.84 | 814,906.30 | -0.3638 | 0.5935 | -0.4325 | 0.7338 | 29.69 | 41.35 | -0.954 | 2.47 | 0.5186 | 1.64 | 0.0682 | 0.00 | 14.38 | 0.561 | -788.26 | -- | -26.87 | -- |
| Scope Fluidics SA | 718.00k | 54.47m | 456.23m | 132.00 | 7.20 | 3.40 | 8.08 | 635.42 | 19.99 | 19.99 | 0.2633 | 42.35 | 0.0065 | 0.9348 | 10.80 | 11,396.83 | 49.25 | 54.44 | 52.79 | 58.98 | -178.69 | -440.53 | 7,586.77 | 33,272.12 | 12.82 | -- | 0.0212 | -- | -74.61 | -- | 448.26 | -- | 5.75 | -- |
| Captor Therapeutics SA | 7.57m | -40.71m | 460.93m | 91.00 | -- | 13.79 | -- | 60.89 | -7.68 | -7.68 | 1.43 | 6.02 | 0.1387 | -- | 4.27 | 83,186.81 | -74.58 | -43.62 | -102.84 | -55.62 | 65.32 | 65.95 | -537.79 | -450.96 | -- | -- | 0.1029 | -- | 19.88 | -- | 45.56 | -- | 13.11 | -- |
| Ryvu Therapeutics SA | 69.80m | -118.69m | 590.72m | 294.00 | -- | 8.29 | -- | 8.46 | -5.13 | -5.13 | 3.02 | 3.08 | 0.212 | 12.29 | 7.31 | 237,411.60 | -36.05 | -23.64 | -48.51 | -27.84 | 70.86 | 29.35 | -170.05 | -208.85 | 2.26 | -- | 0.572 | -- | 66.38 | 83.01 | -20.98 | -- | -24.46 | -- |
| Selvita SA | 373.90m | -2.89m | 807.64m | 434.00 | -- | 2.55 | 15.29 | 2.16 | -0.1577 | -0.1577 | 20.37 | 17.23 | 0.5983 | 8.96 | 4.97 | 398,187.40 | -0.4629 | 5.76 | -0.5715 | 7.33 | 80.27 | 80.65 | -0.7737 | 8.57 | 0.8823 | 0.7538 | 0.3757 | -- | -1.73 | -- | -108.73 | -- | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| AgioFunds TFI SAas of 30 Dec 2025 | 254.41k | 0.30% |
| Dimensional Fund Advisors LPas of 08 Jan 2026 | 238.03k | 0.28% |
| SSgA Funds Management, Inc.as of 08 Jan 2026 | 1.70k | 0.00% |
| DFA Australia Ltd.as of 30 Nov 2025 | 1.34k | 0.00% |
| ANIMA Sgr SpAas of 30 Jun 2025 | 1.00 | 0.00% |
| Dimensional Fund Advisors Ltd.as of 30 Nov 2025 | 0.00 | 0.00% |
